ArticleNature communications2022

Retinoblastoma protein as an intrinsic BRD4 inhibitor modulates small molecule BET inhibitor sensitivity in cancer.

Donglin Ding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.